Clinical Role - Hospital
Pharmacy Times® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.
FDA Analysis Finds Johnson & Johnson Single Shot COVID-19 Vaccine Protects Against Severe Illness, May Reduce Transmission
The FDA could issue an emergency use authorization as soon as this weekend for the single-shot COVID-19 vaccine.
Investigators found significant decreases in heart rate among patients with postural orthostatic tachycardia syndrome who received ivabradine for 1 month.
Paul Ament, PharmD, reviews the guidelines for the treatment of VTE.
This is the third approval for Libtayo, following approvals as the first immunotherapy for patients with advanced basal cell carcinoma and as the first systemic treatment for advanced cutaneous squamous cell carcinoma.
If approved as part of a proposed update to the Emergency Use Authorization, the findings could make Pfizer and BioNTech’s COVID-19 vaccine more widely available.
The investigators said rebuilding public health and other social structures will not only assist disadvantaged groups in times of need, but will also help society at large.
While other factors are causing hospitalizations to fall in the top 10 states, vaccinations could be a significant contributing factor.
Study suggests the major risks to pregnancy are from maternal respiratory illness due to COVID-19 and urged prevention measures as a key to ensure safety.
Health care providers should monitor blood pressure starting in early adolescence, especially for individuals at high cardiovascular risk, such as Black populations.
Megan May, PharmD, BCOP, and Daneng Li, MD, discuss the availability of home-injection programs for patients with NETs, especially during the coronavirus pandemic.
Study suggests that when individuals are expected to wear a mask, people perceive a lower risk with leaving home and visiting public locations.
Implications regarding how to properly treat patients with C. difficile infections based on data that have emerged since clinical practice guidelines were last updated.